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Abstract
Objective: To investigate the temporal ordering of cognitive and functional declines separately in older adults with or
without Alzheimer’s disease (AD).
Design and Setting: A community-based longitudinal study of aging and dementia in Northern Manhattan
(Washington Heights/Hamilton Heights Inwood Columbia Aging Project) and a multicenter, clinic-based longitudinal
study of prevalent AD at Columbia University Medical Center, Johns Hopkins School of Medicine, Massachusetts
General Hospital, and the Hôpital de la Salpêtrière in Paris, France (the Predictors Study).
Participants: 3,443 initially non-demented older adults (612 with eventual incident dementia) and 517 patients with
AD.
Main Outcome Measures: Cognitive measures included the modified Mini-Mental State Exam and composite scores
of memory and language derived from a standardized neuropsychological battery. Function was measured with the
Blessed Dementia Rating Scale, completed by the participant (in the sample of non-demented older adults) or an
informant (in the sample of prevalent AD patients). Data were analyzed with autoregressive cross-lagged panel
analysis.
Results: Cognitive scores more consistently predicted subsequent functional abilities than vice versa in non-
demented older adults, participants with eventual incident dementia, and patients with prevalent AD.
Conclusions: Cognitive declines appear to precede and cause functional declines prior to and following dementia
diagnosis. Standardized neuropsychological tests are valid predictors of later functional changes in both non-
demented and demented older adults.
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Introduction
Empirical investigation into the temporal ordering of
Alzheimer’s disease (AD) signs has largely focused on
cerebrospinal fluid and structural magnetic resonance imaging
biomarkers [1,2]. Behavioral symptoms, including cognitive and
functional decline, appear to follow these physiological
changes in many patients [1].
Many investigators have assumed that cognitive changes
precede functional changes prior to AD diagnosis [1]. Indeed,
the concept of mild cognitive impairment (MCI) was proposed
to describe early cognitive impairment prior to the manifestation
of frank functional loss sufficient to warrant a diagnosis of
dementia [3]. These MCI criteria required that functional
abilities be “essentially normal.” Despite this criterion,
numerous patients labeled with MCI exhibit some degree of
functional impairment [4–6]. In recognition of these
observations, the most recent recommendations of a National
Institute on Aging and Alzheimer’s Association work group
explicitly allow for functional problems in the diagnosis of MCI
due to AD. These new criteria require only that patients
“generally maintain their independence of function in daily life,
with minimal aids or assistance,” thus blurring the temporal
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ordering of cognitive and functional decline in older adults at
risk for dementia [7].
There have been few direct investigations of the temporal
ordering of cognitive and functional declines prior to AD.
Amieva and colleagues reported descriptively that declines in
semantic memory and conceptual formation appeared to
precede declines in activities of daily living in a sample of 350
AD converters [8]. In contrast, a recent community-based
longitudinal study reported that baseline difficulties with certain
informant-reported instrumental activities of daily living among
cognitively intact individuals predicted MCI two years later [9].
Further, it has been suggested that a structured clinical
interview focusing on functional changes is capable of
diagnosing AD prior to the inflection point of cognitive decline
[10]. Indeed, standardized neuropsychological tests have been
criticized in their ability to predict future functional declines [11].
Thus, it remains possible that functional changes precede
measurable cognitive changes, or that there is reciprocal
causality between cognition and function prior to dementia
onset.
The temporal ordering of cognitive and functional declines
following AD diagnosis has largely been ignored. We recently
demonstrated strong coupling of cognitive and functional
declines both between and within patients diagnosed with
probable AD [12]. However, whether there are leading and
lagging relationships within those parallel trajectories remains
unclear.
The purpose of this study was to investigate the temporal
ordering of cognitive and functional declines separately in older
adults with or without AD. In both samples, cognition was
measured with neuropsychological tests, and function was
measured using a self-report questionnaire completed by either
the individual (in the sample of non-demented older adults) or
an informant (in the sample of AD patients). We used
autoregressive cross-lagged panel analysis to compare the
predictive abilities of the cognitive variables for function versus
functional variables for cognition. This approach allows for an
exploration of reciprocal causality between cognition and
function.
Methods
Data from two longitudinal studies were used in the present
analyses. A sample of initially non-demented older adults was
drawn from the Washington Heights/Hamilton Heights Inwood
Columbia Aging Project (WHICAP) [13,14]. A sample of
prevalent Alzheimer’s disease (AD) cases was drawn from The
Predictors Study, a multicenter study of AD progression [15].
Ethics Statement
The local Institutional Review Board (IRB) at Columbia
University approved the WHICAP study. Written informed
consent was obtained from all WHICAP participants. Local IRB
at all participating sites approved The Predictors Study. Written
informed consent was obtained directly from patients at study
entry. Patient assent was documented at each subsequent visit
in accordance with IRB requirements.
WHICAP
Participants and procedures.  WHICAP is a prospective,
community-based study of aging and dementia in a racially and
ethnically diverse sample of Medicare-eligible residents of
Northern Manhattan. Participants were identified from Medicare
records and recruited in two waves: 1992 (N=1,486) and 1999
(N=1,957). Ongoing follow-up occurs at 18-24 month intervals
and includes a battery of cognitive, functional, and health
measures administered in the participant’s preferred language
(English or Spanish). We have previously demonstrated
acceptable measurement and structural invariance of our
neuropsychological battery across English and Spanish
speakers [16].
The current sample included 3,443 participants who did not
meet criteria for dementia at their initial study visit. Dementia
was determined by a consensus of a group of neurologists and
neuropsychologists using Diagnostic and Statistical Manual of
Mental Disorders, Revised Third Edition criteria [17]. To
maximize the available data, only data from the first four
occasions were analyzed for all participants, corresponding to
an average follow-up period of 5.1 years (SD =2.4). The
median number of visits was 3. Average time between
assessments was 2.2 years (SD =1.0). Among the 612
participants who converted to dementia during the entire
WHICAP study period (up to 22 years), 230 converted at the
second study visit, 133 converted at the third study visit, 108
converted at the fourth study visit, and 140 converted at a
future study visit (up to 22 years). Because only the first four
visits were analyzed, data from the visit at which these 140
participants converted to dementia was not analyzed.
Characteristics of the WHICAP sample are available in Table 1.
Measures.  Cognition was evaluated with tests of episodic
memory and language. Episodic memory was chosen due to its
central role in dementia progression. Language was chosen
based on evidence that verbal fluency and verbal abstraction
evidence the earliest declines prior to dementia diagnosis [8].
Tests were grouped into cognitive domains based on previous
Table 1. Patient Characteristics at Study Enrollment.
 WHICAP total WHICAP incident Predictors
 (N=3,443) (N=612) (N=517)
Age 76.3 (6.4) 78.29 (6.8) 74.2 (8.5)
Education 9.8 (4.8) 7.5 (4.7) 13.7 (3.6)
Sex (% Female) 67.4 72.2 56.9
Race (% White) 27.1 13.6 93.2
Ethnicity (% Non-Hispanic) 60.3 55.4 95.2
Anti-dementia medications (%
yes) 0.8 1.1 31.1
a
Note. WHICAP=Washington/Hamilton Heights Inwood Columbia Aging Project,
Predictors = The Predictors Study of Alzheimer’s disease.
a Only participants recruited after 1997 reported taking anti-dementia medication at
study entry.
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factor analysis of the WHICAP battery [16]. Raw scores at each
occasion were standardized to T-score metric using the
sample’s means and standard deviations at the initial occasion.
Composite scores for each occasion were computed by
averaging the three T-scores at that occasion within each
domain.
The episodic memory domain included measures from the
Selective Reminding Test (SRT) [18]. Participants are given six
trials to learn a list of 12 words. Following each trial,
participants are only reminded of the words they failed to recall.
Total learning is quantified as the total number of words
recalled after the six learning trials. Delayed recall and
recognition are quantified as the number of words recalled or
recognized after a 15-minute delay.
The language domain included measures of naming, verbal
fluency, verbal abstraction, repetition, and comprehension.
Naming ability was quantified as the number of spontaneously-
identified objects on a 15-item version of the Boston Naming
Test [19]. Verbal fluency was assessed for both letters and
animals. Verbal abstraction was assessed with the Similarities
subtest of the Wechsler Adult Intelligence Scale – Revised [20].
Repetition and comprehension were assessed with subtests of
the Boston Diagnostic Aphasia Examination [21].
Functional abilities were assessed with items from the
Blessed Dementia Rating Scale (BDRS) [22]. In WHICAP, the
BDRS is a self-report instrument that asks about difficulties
performing various activities of daily living for non-physical
reasons. The sum of items specifically assessing instrumental
(1,2,4,5) and basic (9–11) activities of daily living were used.
Scores range from 0 to 13, with higher scores indicating
greater functional difficulty. Scores on the cognitive and
functional measures in the WHICAP sample are shown in
Table 2.
Covariates.  In line with prior work with this dataset, models
controlled for age, sex, race, ethnicity, education, recruitment
year, and illness burden. Race and ethnicity were determined
via self-report using the format of the 2000 US Census. To
quantify illness burden at each occasion, one point was
assigned for the presence of each of the following conditions:
heart disease, hypertension, stroke, diabetes, pulmonary
disease, thyroid disease, liver disease, renal insufficiency,
peptic ulcer disease, peripheral vascular disease, cancer,
Parkinson’s disease, Essential Tremor, Multiple Sclerosis, and
arthritis. These points were summed to create an index of
illness burden at each occasion.
The Predictors Study
Participants and procedures.  The current sample included
517 patients with probable AD recruited in two waves
beginning in 1989 (N=252) or 1998 (N=265) from clinics at four
sites: Columbia University Medical Center (N=208), Johns
Hopkins School of Medicine (N=147), Massachusetts General
Hospital (N=124), and the Hôpital de la Salpêtrière in Paris,
France (N=38). Diagnoses of probable AD were made using
NINCDS-ADRDA criteria [23] at consensus conferences. At
enrollment, all patients were required to have mild dementia
(i.e., score above 29 on the 57-point Modified Mini Mental State
Exam, described below) and at least one family member/
caregiver available. Exclusion criteria were non-AD dementia,
parkinsonism, stroke, alcoholism, schizophrenia,
schizoaffective disorder, and electroconvulsive treatments.
Participants were assessed every 6-months. At least one
follow-up assessment was available for 97% of the present
sample. On average, patients were assessed on 10 occasions
(SD=5.9). Only data from the first 12 occasions (six years)
were included in the present study to maximize available data.
Average attrition rate between visits was 8.5%, and 176
participants were assessed at the last visit. Characteristics of
the Predictors sample are shown in Table 1.
Measures.  Cognition was measured using the Modified Mini
Mental State Exam (mMMS) [24]. In addition to items from the
Mini Mental State Exam [25], the mMMS includes items
assessing working memory, calculation, recall of the current
and four previous presidents of the United States, confrontation
naming, repetition, and visuoconstruction. The scale was
translated and modified for assessments at the Paris site.
Scores range from 0 to 57, with higher scores indicating better
cognitive functioning.
Functional abilities were assessed with items from the BDRS
[22]. In The Predictors Study, the BDRS is a semi-structured
interview conducted with an informant that assess a patient’s
difficulties performing various activities of daily living for non-
physical reasons. As described above, the sum of items
specifically assessing instrumental and basic activities of daily
living were used. Scores range from 0 to 13, with higher scores
indicating greater functional difficulty. Scores on the cognitive
and functional measures in The Predictors Study sample are
shown in Table 2.
Covariates.  In line with prior work with this dataset, the
Predictors model controlled for age, sex, education, and
Table 2. Scores at Each Visit.
 Memory Language mMMS BDRS
WHICAP     
Visit 1 50.1 (8.4) 50.1 (7.5) - 0.7 (1.1)
Visit 2 48.0 (10.4) 49.9 (7.9) - 0.7 (1.6)
Visit 3 47.5 (10.5) 50.1 (7.7) - 0.7 (1.7)
Visit 4 47.6 (10.5) 49.3 (8.1) - 0.9 (1.8)
The Predictors Study     
Visit 1 - - 37.6 (6.4) 1.9 (1.7)
Visit 2 - - 35.4 (8.5) 2.4 (2.1)
Visit 3 - - 33.0 (10.1) 3.1 (2.7
Visit 4 - - 30.8 (10.9) 3.8 (3.1)
Visit 5 - - 29.4 (12.0) 4.2 (3.2)
Visit 6 - - 27.3 (12.9) 4.9 (3.5)
Visit 7 - - 25.6 (14.2) 5.4 (3.7)
Visit 8 - - 24.6 (13.8) 5.8 (3.6)
Visit 9 - - 24.0 (14.2) 6.3 (3.8)
Visit 10 - - 22.0 (15.1) 6.9 (3.9)
Visit 11 - - 22.9 (14.9) 7.1 (3.9)
Visit 12 - - 22.2 (14.0) 7.7 (3.9)
Note. WHICAP= WHICAP=Washington/Hamilton Heights Inwood Columbia Aging
Project, mMMS = Modified Mini-Mental State Exam, BDRS = Blessed Dementia
Rating Scale.
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recruitment site. In a subset of 265 participants recruited in
1998, data were available to quantify illness burden at each
occasion. Specifically, one point was assigned for the presence
of each of the following conditions: hypertension, diabetes,
myocardial infarction, congestive heart failure, valvular heart
disease, angina, atrial fibrillation, other cardiac arrhythmia,
hypercholesterolemia, hypertriglyceridemia, epilepsy, head
trauma with loss of consciousness, pulmonary disease, thyroid
disease, chronic liver disease, chronic renal disease, systemic
malignancy, autoimmune disorder, and syphilis. These points
were summed to create an index of illness burden at each
occasion.
Statistical analysis
Descriptive statistics were computed in SPSS version 19
(IBM Corp., Amonk, NY). Bivariate autoregressive cross-lagged
panel analyses were conducted in Mplus version 7 (Muthén &
Muthén, Los Angeles, CA) using maximum likelihood
estimation. Missing data were managed with full information
maximum likelihood (FIML), which uses all available data for
parameter estimation.
In the cross-lagged models, each variable at each occasion
was regressed onto the same variable at the previous occasion
(autoregressive paths) as well as the other variable of interest
at the previous occasion (cross-lagged paths). In addition,
occasion-specific correlations between the two variables of
interest were estimated. A schematic of the general model is
shown in Figure 1. This framework allows for an exploration of
reciprocal causality between cognitive and functional variables.
In the current study, three cross-lagged models were
estimated. The first two examined relationships between
function and one of the two cognitive abilities in WHICAP (i.e.,
memory or language) over an average of five years. In
addition, these models were re-run on the subset of 612
individuals who converted to dementia during the study period
in order to more specifically examine temporal ordering prior to
confirmed dementia onset. The third model examined the
relationship between function and global cognitive status in The
Predictors Study over 5.5 years. In the subset of 265
participants recruited in 1998, a supplementary model was run
in which a time-varying covariate reflecting illness burden was
added to the model to confirm that results were not
dramatically altered by the consideration of comorbid health
conditions. Due to this smaller sample size used in this
analysis, only 2.5 years of data were evaluated. Model fit was
evaluated with the root mean square error of approximation
(RMSEA<0.08), standardized root mean square residual
(SRMR<0.05), and the comparative fit index (CFI>.95).
Results
WHICAP
Memory (RMSEA=0.05, SRMR=0.03, CFI=0.95) and
language (RMSEA=0.05, SRMR=0.03, CFI=0.97) models fit
Figure 1.  Schematic of the autoregressive cross-lagged model.  Four time points were analyzed in the WHICAP models.
Twelve time points were analyzed in the Predictors model. Refer to the text for the covariates included in each model (not shown).
doi: 10.1371/journal.pone.0073645.g001
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well. After controlling for covariates, better functional ability was
associated with higher concomitant memory (pooled r=-0.32; all
p’s<.001) and language (pooled r=-0.33; all p’s<.001) scores at
all four visits. Autoregressive and cross-lagged paths in the two
models are shown in Table 3. Memory and language scores
predicted functional ability at each subsequent visit. In contrast,
functional ability only predicted subsequent memory or
language scores at two out of three follow-up visits.
Standardized regression coefficients were larger for the
prediction of functional ability by cognitive domain at each visit.
In the restricted sample of incident dementia cases, memory
(RMSEA=0.05, SRMR=0.05, CFI=0.96) and language
(RMSEA=0.04, SRMR=0.05, CFI=0.97) models fit well. After
controlling covariates, better functional ability was associated
with higher memory scores at visits 2 through 4 (pooled
r=-0.37; all p’s<.008). At the first visit, the association between
function and memory was not significant (r=.10, p=.062). Better
Table 3. Results from the WHICAP models.
  Model 1: Memory
Model 2:
Language
  Estimate (SE) Estimate (SE)
Predictors of
function    
Visit 2 function on    
 Visit 1 function 0.59** (0.02) 0.59** (0.02)
 Visit 1 cognition -0.07** (0.02) -0.12** (0.03)
Visit 3 function on    
 Visit 2 function 0.60** (0.02) 0.59** (0.02)
 Visit 2 cognition -0.15** (0.02) -0.13** (0.02)
Visit 4 function on    
 Visit 3 function 0.62** (0.02) 0.62** (0.02)
 Visit 3 cognition -0.18** (0.03) -0.19** (0.03)
Predictors of
cognition    
Visit 2 cognition on    
 Visit 1 cognition 0.58** (0.01) 0.78** (0.01)
 Visit 1 function -0.06** (0.02) -0.06** (0.01)
Visit 3 cognition on    
 Visit 2 cognition 0.66** (0.02) 0.74** (0.01)
 Visit 2 function -0.07* (0.02) -0.04* (0.02)
Visit 4 cognition on    
 Visit 3 cognition 0.68** (0.02) 0.80** (0.02)
 Visit 3 function -0.03 (0.03) 0.01 (0.03)
Note. SE = Standard Error. Models controlled for age, sex, race, ethnicity,
education, and recruitment year. Presented estimates are in standardized metric.
* p<.05, **p<.001
functional ability was also associated with higher language
scores at the all four visits (pooled r=-0.35; all p’s <.05). With
regard to cross-lagged paths, memory and language scores
predicted subsequent functional ability at follow-up visits 3
(memory: beta=-0.10, p=.03, language: beta=-0.13, p=.005)
and 4 (memory: beta=-0.20, p<.001, language: beta=-0.18, p=.
002). In contrast, functional ability did not predict subsequent
memory or language scores at any of the follow-up visits (all
p’s >.07).
The Predictors Study
The model fit well (RMSEA=0.04, SRMR=0.03, CFI=0.98). At
all twelve occasions, better functional ability was associated
with higher global cognitive status (pooled r=-0.64; all p’s<.
001). With regard to the autoregressive paths, previous
functional ability predicted subsequent functional ability at each
visit (pooled beta=0.78, pooled SE= 0.03, all p’s<.001).
Similarly, previous global cognitive status predicted subsequent
global cognitive status at each visit (pooled beta=0.91, pooled
SE= 0.02, all p’s<.001). Cross-lagged paths are shown in Table
4. As shown, global cognitive status predicted functional ability
at each subsequent visit. In contrast, functional ability only
predicted global cognitive status at three out of the 11 follow-up
visits. Standardized regression coefficients were larger for the
prediction of functional ability by cognition at each visit.
A supplementary model was run in the subset of 265
participants recruited in 1998 adding a time-varying covariate
reflecting illness burden. This model fit well (RMSEA=0.07,
SRMR=0.05, CFI=0.97). Better functional ability was
associated with higher global cognitive status at the first five
occasions (pooled r=-0.47; all p’s<.013). With regard to the
Table 4. Results from The Predictors Study model.
 Predictor of function
Predictor of global cognitive
status
 Estimate (SE) Estimate (SE)
Visit2 on Visit1 -0.15** (0.03) -0.14** (0.03)
Visit3 on Visit2 -0.17** (0.03) -0.05 (0.03)
Visit4 on Visit3 -0.16** (0.03) -0.06* (0.03)
Visit5 on Visit4 -0.14** (0.03) -0.07* (0.03)
Visit6 on Visit5 -0.20** (0.03) 0.02 (0.03)
Visit7 on Visit6 -0.07* (0.03) -0.05 (0.03)
Visit8 on Visit7 -0.15** (0.03) -0.00 (0.03)
Visit9 on Visit8 -0.18** (0.04) 0.01 (0.03)
Visit10 on Visit9 -0.13* (0.04) 0.03 (0.03)
Visit11 on Visit10 -0.15* (0.05) 0.00 (0.03)
Visit12 on Visit11 -0.25** (0.05) 0.03 (0.05)
Note. SE = Standard Error. Models controlled for age, sex, education, and
recruitment site. Presented estimates are in standardized metric.
* p<.05, **p<.001
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autoregressive paths, previous functional ability predicted
subsequent functional ability at each visit (pooled beta=0.75,
pooled SE= 0.05, all p’s<.001). Similarly, previous global
cognitive status predicted subsequent global cognitive status at
each visit (pooled beta=0.88, pooled SE= 0.04, all p’s<.001).
With regard to cross-lagged paths, global cognitive status
predicted functional ability at each subsequent visit (pooled
beta=-0.16, pooled SE= 0.06, all p’s<.03). In contrast,
functional ability only predicted global cognitive status at the
second visit (beta=-0.13, SE= 0.06, p=.02). Standardized
regression coefficients were larger for the prediction of
functional ability by cognition at each visit.
Discussion
The main finding was that cognitive score more consistently
predicted subsequent functional ability than vice versa in both
non-demented older adults and patients with Alzheimer’s
disease (AD). Among non-demented older adults, composites
scores of memory or language reliably predicted self-reported
functional ability at every subsequent visit, whereas self-
reported functional ability only predicted subsequent cognitive
scores two-thirds of the time. In addition, standardized
regression coefficients were larger for the prediction of
functional ability by cognitive domain. Restricting the sample to
incident dementia cases, cognitive score predicted subsequent
functional ability at two of the three follow-up visits, while
functional scores did not predict subsequent cognitive scores at
any visit. Among patients with prevalent AD, cognitive score
predicted informant-rated functional ability at each subsequent
visit, whereas functional ability only predicted subsequent
cognition at three out of 11 follow-up visits. Further, the
magnitude of association between cognitive score and
subsequent functional ability was larger than that between
functional score and subsequent cognition for every visit.
These findings were independent of chronic illness burden and
are most consistent with the view that cognitive declines
precede functional declines.
These results validate the use of neuropsychological tests for
functional prognosis among older adults with and without AD. It
is notable that a previous study reporting poor prognostic ability
of neuropsychological tests did not examine cognitive abilities
assessed in the present study: word list learning, basic
language ability, and verbal abstraction [11]. Together, these
results support the importance of assessing memory and
language with tests that require greater executive demands to
detect the earliest deficits of AD [26].
Results provide minimal evidence for reciprocal causality
between cognition and function and clarify our earlier
demonstration of tight coupling of cognitive and functional
declines over the course of AD by showing that decrements in
the ability to perform tasks of daily living temporally follow and
are predicted by decrements in cognition [12]. Thus, it appears
likely that functional impairment in AD is a direct result of
cognitive impairment.
Importantly, our finding that cognitive declines preceded
functional declines in the sample of initially non-demented older
adults was replicated, and even more pronounced, in the
subset of participants who went on to develop dementia. The
interaction between cognitive and functional decline appears to
begin prior to formal dementia diagnosis. It has been
suggested that the Clinical Dementia Rating (CDR), a
comprehensive clinical interview focusing on real-world
functioning, is sufficient to diagnose dementia prior to the
inflection point of cognitive decline [10]. However, it should be
noted that the CDR is much more than a functional scale. Not
only does it assess activities of daily living, it includes a more
wide-ranging clinical interview with both patient and
knowledgable informant. It also involves direct interrogation of
cognitive abilities (e.g., recall of a name and address). Such a
comprehensive clinical interview supplemented by overt
cognitive testing represents the gold standard in clinical
diagnosis and prognosis. Our results show that in the absence
of such thorough clinical assessment, standardized
neuropsychological testing is also capable of predicting later
changes in functioning.
There were minimal differences in the observed temporal
associations in the two populations studied (a community-
based study of initially non-demented older adults and a clinic-
based study of older adults with prevalent AD). In the initially
non-demented sample, associations between cognition and
subsequent function were somewhat stronger for later time
points, perhaps because these variables became more coupled
as cognitive and functional abilities declined. Indeed, the
magnitudes of association between the cognitive variables and
subsequent functioning at these later time points were similar
to those seen between global cognitive status and subsequent
functioning in the prevalent AD sample.
Amieva and colleagues (2008) have descriptively shown that
declines in cognitive performance appear to precede declines
in activities of daily living prior to AD diagnosis [8]. The current
findings extend this observation by showing that cognitive
scores significantly and independently predicted functional
scores at subsequent visits. While the magnitudes of the
associations between cognition and subsequent function were
similar at later visits, language scores at the initial study visit
appeared to be a stronger predictor of functioning at the
second visit than memory scores. These results may be
consistent with those of Amieva et al. (2008), who reported that
verbal fluency and verbal abstraction, both of which were
included in our language composite, were the first tests to
evidence declines prior to AD conversion in their French
sample. Alternatively, function could have been more sensitive
to declines in language than memory if both domains declined
similarly in the present study.
A main strength of this study is its large numbers of older
adults both prior to and following dementia onset. Another
strength is the use of panel analysis, which allowed for a direct
examination of the temporal ordering of cognitive and
functional changes. While cognitive scores were limited to a
single measure of global cognitive status in the AD sample, we
were able to replicate our results with composite scores of
memory and language tests in the sample of initially non-
demented older adults. A limitation of analyses on the WHICAP
sample was the lack of an informant-based measure of
function, as the presence of a reliable informant was not an
Cognitive Declines Predict Functional Declines
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inclusion criterion for this community-based study. It should be
noted that the same pattern of results (i.e., cognitive declines
precede and predict functional declines) was found in the
Predictors sample, in which function was measured via
informant report.
In conclusion, the present study supports the view that
cognitive declines precede and cause functional declines in
late life. In addition, standardized neuropsychological tests
represent a useful marker of functional prognosis during all
stages of dementia. While the current study cannot address the
temporal ordering of biomarkers as described by Jack et al.
(2010, 2013) [1,2], our findings support the hypothesis that
cognitive changes precede functional changes prior to AD
diagnosis as depicted in that model.
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